CH642046A5 - 1alpha-hydroxycalcioic-saeure und ester davon. - Google Patents

1alpha-hydroxycalcioic-saeure und ester davon. Download PDF

Info

Publication number
CH642046A5
CH642046A5 CH646580A CH646580A CH642046A5 CH 642046 A5 CH642046 A5 CH 642046A5 CH 646580 A CH646580 A CH 646580A CH 646580 A CH646580 A CH 646580A CH 642046 A5 CH642046 A5 CH 642046A5
Authority
CH
Switzerland
Prior art keywords
acid
methanol
vitamin
ester
hydroxycalcioic
Prior art date
Application number
CH646580A
Other languages
German (de)
English (en)
Inventor
Hector F Deluca
Heinrich K Schnoes
Robert P Esvelt
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of CH642046A5 publication Critical patent/CH642046A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH646580A 1978-12-29 1979-12-06 1alpha-hydroxycalcioic-saeure und ester davon. CH642046A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/000,440 US4209634A (en) 1978-12-29 1978-12-29 1α-Hydroxycalcioic acid and esters thereof

Publications (1)

Publication Number Publication Date
CH642046A5 true CH642046A5 (de) 1984-03-30

Family

ID=21691549

Family Applications (1)

Application Number Title Priority Date Filing Date
CH646580A CH642046A5 (de) 1978-12-29 1979-12-06 1alpha-hydroxycalcioic-saeure und ester davon.

Country Status (9)

Country Link
US (1) US4209634A (US20100056889A1-20100304-C00004.png)
JP (1) JPS6310947B2 (US20100056889A1-20100304-C00004.png)
CH (1) CH642046A5 (US20100056889A1-20100304-C00004.png)
DE (1) DE2953443C2 (US20100056889A1-20100304-C00004.png)
FR (1) FR2445315B1 (US20100056889A1-20100304-C00004.png)
GB (1) GB2043074B (US20100056889A1-20100304-C00004.png)
IE (1) IE49347B1 (US20100056889A1-20100304-C00004.png)
IL (1) IL58976A (US20100056889A1-20100304-C00004.png)
WO (1) WO1980001379A1 (US20100056889A1-20100304-C00004.png)

Also Published As

Publication number Publication date
DE2953443C2 (de) 1986-12-11
FR2445315B1 (fr) 1986-04-11
GB2043074A (en) 1980-10-01
JPS6310947B2 (US20100056889A1-20100304-C00004.png) 1988-03-10
FR2445315A1 (fr) 1980-07-25
IL58976A0 (en) 1980-03-31
US4209634A (en) 1980-06-24
JPS55501100A (US20100056889A1-20100304-C00004.png) 1980-12-11
WO1980001379A1 (en) 1980-07-10
DE2953443T1 (US20100056889A1-20100304-C00004.png) 1980-12-11
IE49347B1 (en) 1985-09-18
IL58976A (en) 1982-12-31
IE792520L (en) 1980-06-29
GB2043074B (en) 1982-12-22

Similar Documents

Publication Publication Date Title
DE3390212C2 (US20100056889A1-20100304-C00004.png)
DE2012167C2 (de) 25-Hydroxycholecalciferol-hydrat und Verfahren sowie Zwischenprodukte zu seiner Herstellung
DE1643738B1 (de) 7-[3alpha,5alpha-Dihydroxy-2-(3-hydroxyoctenyl-(1))-cyclopentyl]-heptan-1-ol,dessen Tetraacetat und Verfahren zu deren Herstellung
DE2929517A1 (de) Pinenderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
CH652725A5 (de) Zwischenprodukte fuer die herstellung eines vitamin d(3)-derivates.
CH650237A5 (de) 1-fluorierte vitamin d verbindungen.
DE3390016T1 (de) Verfahren zur Herstellung von 26,26,26-27,27,27-Hexafluor-1α,25-Dihydroxycholesterin
DE4011682A1 (de) 24-oxa-derivate in der vitamin d-reihe
DE2326008C3 (de) Verfahren zur Herstellung von 25-Hydroxycholesterin und dessen Ester
DE3152229C2 (US20100056889A1-20100304-C00004.png)
DE3243073A1 (de) 23-dehydro-25-hydroxyvitamin d(pfeil abwaerts)3(pfeil abwaerts)
DE2953443C2 (de) 1ALPHA, 3beta-DIHYDROXY-9,10-seco-24-Norchola-5,7,10,(19)-trien-23-SAEURE UND ESTER DAVON.
DE2322893A1 (de) Prostaglandin e tief 1 -vorprodukte und verfahren zu ihrer herstellung
DE2733204C3 (de) Verfahren zur Isolierung von Äscin aus Früchten der Roßkastanie
DE3045288C2 (US20100056889A1-20100304-C00004.png)
DE3243150A1 (de) Trihydroxy-vitamin-d(pfeil abwaerts)3(pfeil abwaerts)-verbindungen
DE1933375C3 (de) 25 Hydroxyverbindungen der Vitamin D Reihe, Verfahren zu ihrer Herstellung und 25 Hydroxycholecalciferol enthalten des Mittel
DE1643159A1 (de) Verfahren zur Herstellung von Prostaglandinderivaten und Verbindungen mit prostaglandin-aehnlicher Aktivitaet
DE2812741A1 (de) Vitamin d tief 3 -derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
EP0757055A2 (de) Neue Glykoside, deren zuckerfreie Abbauprodukte und Derivate derselben
CH642071A5 (de) 25-hydroxycholecalciferol-26,23-lacton.
EP0753510B1 (de) Verfahren zur Herstellung von 9,10-Secocholesta-5,7,10(19)-trienen
DE1793478A1 (de) Alisol-Verbindungen
DE1568308C3 (de) 10.09.65 Schweiz 12624-65 Verfahren zur Herstellung von Delta hoch 4,9,11-Trienen der 19-Norandrostanreihe, 17-oxygenierte 3-Oxo-7 alpha-methyl-Delta hoch 4,9,11-19 norandrostatriene und diese enthaltende pharmazeutische Präparate sowie 3-Oxo-7 alpha -methyl-Delta hoch 5 (10), 9 (11) -19-norandrostadiene
DE3433188A1 (de) Ursodesoxycholsaeure-derivat, verfahren zu seiner herstellung und solch ein derivat enthaltende pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
PL Patent ceased